CellSource Co

CellSource Co Gross Margin

The Gross Margin of CellSource Co (4880.T) as of Oct 27, 2026 is 56.24 %. In the previous year, Gross Margin was 54.25 % — a change of 3.68% (higher).

Gross Margin

56.24 %

YoY

3.68%

Last updated:

Gross Margin of CellSource Co is 2025 56.24 % . Gross Margin of CellSource Co was 2024 54.25 % . It decreases by 3.68% higher compared to the previous year.

For CellSource Co, the gross margin of 56.3% is down versus 70.6% a few years ago.

The CellSource Co Gross Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Gross Margin
Date
Gross Margin
Jan 1, 2018
72.00 JPY
Jan 1, 2019
71.16 JPY
Jan 1, 2020
67.42 JPY
Jan 1, 2021
70.58 JPY
Jan 1, 2022
71.39 JPY
Jan 1, 2023
70.05 JPY
Jan 1, 2024
54.25 JPY
Jan 1, 2025
56.24 JPY
The CellSource Co Gross Margin history
YEARGross MarginYoY
56.24 %+3.68%
54.25 %-22.56%
70.05 %-1.88%
71.39 %+1.14%
70.58 %+4.70%
67.42 %-5.26%
71.16 %-1.16%
72.00 %+24.60%
57.78 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

CellSource Co Stock analysis

What does CellSource Co do? CellSource Co., Ltd. generates revenue through its Regenerative Medicine Related business segment, which provides contracted services for processing tissues and cells from fat and blood to medical institutions, along with support services for regenerative medicine laws and regulations related to safety assurance. The company also sells medical equipment within this segment. The Consumer business segment focuses on selling cosmetics and facial products directly to general consumers. Both segments operate under the company's brand without additional brand names mentioned in the description. The Regenerative Medicine Related business segment targets medical institutions and regulatory compliance support for regenerative medicine safety, while the Consumer business segment serves general consumers seeking cosmetics and facial care products. The company's products include processed tissue and cell services, regulatory support, medical equipment, and consumer skincare items, all sold under the CellSource brand. CellSource Co., Ltd. employs 109 full-time employees to manage its two business segments, with the Regenerative Medicine Related segment handling medical services and equipment sales, and the Consumer segment focusing on direct-to-consumer product sales. The company's revenue streams are derived from these two distinct operational areas without any additional external partnerships or third-party brands. CellSource Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about CellSource Co stock

Gross Margin of CellSource Co is 56.24 % in 2025.

Gross Margin of CellSource Co changed from 54.25 % to 56.24 %, representing a 3.68% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin CellSource Co since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's CellSource Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — CellSource Co

All Key Metrics — CellSource Co